Literature DB >> 29861204

Accounting for Complexity in Home Telemonitoring: A Need for Context-Centred Evidence.

Patrick Ware1, Emily Seto2, Heather J Ross3.   

Abstract

Heart failure represents a significant burden for patients and the Canadian health care system. Home telemonitoring is proposed as an intervention that can improve heart failure outcomes by identifying opportunities for earlier clinical intervention and by providing patients with self-management support between scheduled clinic visits. The objective of this review is to provide clarity with respect to the most recent evidence of the effect of home telemonitoring on heart failure outcomes. Despite some strong evidence that telemonitoring can reduce the risk of mortality and heart failure-related hospitalizations, important inconsistencies exist in the evidence. This article proposes that much of the inconsistency results from differences in the patient population being studied, the type of home telemonitoring intervention, and the implementation setting. Also important is the degree to which intervention fidelity is maintained throughout the course of a study; this is emphasized through a review of the factors that influence the degree to which patients and health care providers use home telemonitoring interventions as intended. In this article we propose that for researchers to produce definitive answers regarding the effect of home telemonitoring on heart failure outcomes, interventions and studies need to be designed and tailored according to the characteristics of the target patient population and the implementation context.
Copyright © 2018 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 29861204     DOI: 10.1016/j.cjca.2018.01.022

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  7 in total

1.  Home Telehealth Technologies for Heart Failure: An Examination of Adherence Among Veterans.

Authors:  Jenice Guzman-Clark; Maria Yefimova; Melissa M Farmer; Bonnie J Wakefield; Benjamin Viernes; Martin L Lee; Theodore J Hahn
Journal:  J Gerontol Nurs       Date:  2020-07-01       Impact factor: 1.254

2.  Patient Adherence to a Mobile Phone-Based Heart Failure Telemonitoring Program: A Longitudinal Mixed-Methods Study.

Authors:  Patrick Ware; Mala Dorai; Heather J Ross; Joseph A Cafazzo; Audrey Laporte; Chris Boodoo; Emily Seto
Journal:  JMIR Mhealth Uhealth       Date:  2019-02-26       Impact factor: 4.773

3.  Outcomes of a Heart Failure Telemonitoring Program Implemented as the Standard of Care in an Outpatient Heart Function Clinic: Pretest-Posttest Pragmatic Study.

Authors:  Patrick Ware; Heather J Ross; Joseph A Cafazzo; Chris Boodoo; Mikayla Munnery; Emily Seto
Journal:  J Med Internet Res       Date:  2020-02-08       Impact factor: 5.428

4.  Implementation and Evaluation of a Smartphone-Based Telemonitoring Program for Patients With Heart Failure: Mixed-Methods Study Protocol.

Authors:  Patrick Ware; Heather J Ross; Joseph A Cafazzo; Audrey Laporte; Emily Seto
Journal:  JMIR Res Protoc       Date:  2018-05-03

5.  A Mobile Phone-Based Telemonitoring Program for Heart Failure Patients After an Incidence of Acute Decompensation (Medly-AID): Protocol for a Randomized Controlled Trial.

Authors:  Emily Seto; Heather Ross; Alana Tibbles; Steven Wong; Patrick Ware; Edward Etchells; Jeremy Kobulnik; Tamanna Chibber; Stephanie Poon
Journal:  JMIR Res Protoc       Date:  2020-01-22

6.  User-Centered Adaptation of an Existing Heart Failure Telemonitoring Program to Ensure Sustainability and Scalability: Qualitative Study.

Authors:  Patrick Ware; Heather J Ross; Joseph A Cafazzo; Audrey Laporte; Kayleigh Gordon; Emily Seto
Journal:  JMIR Cardio       Date:  2018-12-06

7.  Evaluation of a Heart Failure Telemonitoring Program Through a Microsimulation Model: Cost-Utility Analysis.

Authors:  Chris Boodoo; Qi Zhang; Heather J Ross; Ana Carolina Alba; Audrey Laporte; Emily Seto
Journal:  J Med Internet Res       Date:  2020-10-06       Impact factor: 5.428

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.